New survey shows that over 90% of animal owners trust and appreciate veterinary teams but underestimate the demands of the profession
Notified -
Globe Newswire24-04-2025, 15:00
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00